Alzheimer's Disease
Showing NaN - NaN of 77
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)
Recruiting
- Alzheimer's Disease
- Placebo
- Bepranemab
-
Sun City, Arizona
- +115 more
Aug 18, 2022
Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)
Recruiting
- Alzheimer's Disease
- Remternetug (IV)
- +2 more
-
Chandler, Arizona
- +70 more
Aug 10, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Phoenix, Arizona
- +180 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Birmingham, Alabama
- +179 more
Aug 9, 2021
Alzheimer's Disease Trial in New Haven (saracatinib, Placebo)
Completed
- Alzheimer's Disease
- saracatinib
- Placebo
-
New Haven, ConnecticutYale Alzheimer's Disease Research Unit
Apr 22, 2021
Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)
Completed
- Alzheimer's Disease
- florbetapir F 18
- +2 more
-
Phoenix, Arizona
- +26 more
Sep 3, 2020
Alzheimer's Disease, Traumatic Brain Injury, Depression Trial in United States (Flortaucipir F18, Brain PET scan)
Completed
- Alzheimer's Disease
- +2 more
- Flortaucipir F18
- Brain PET scan
-
Phoenix, Arizona
- +4 more
Aug 21, 2020
Alzheimer's Disease Trial in Newport Beach, New Haven (Flortaucipir F18, Brain PET scan)
Completed
- Alzheimer's Disease
- Flortaucipir F18
- Brain PET scan
-
Newport Beach, California
- +1 more
Aug 20, 2020
Alzheimer's Disease Trial in New Haven (Flortaucipir F18)
Completed
- Alzheimer's Disease
- Flortaucipir F18
-
New Haven, ConnecticutMolecular NeuroImaging
Jul 27, 2020
Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
- Placebo
-
Tucson, Arizona
- +31 more
Jul 31, 2020
Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)
Alzheimer's Disease Trial in Worldwide (Crenezumab)
Terminated
- Alzheimer's Disease
-
Newport Beach, California
- +65 more
Jun 25, 2020
Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)
Terminated
- Alzheimer's Disease
- Behavioral Variant Frontotemporal Dementia
-
Phoenix, Arizona
- +134 more
May 15, 2020
Amnestic Mild Cognitive Impairment, Alzheimer's Disease Trial in United States (Insulin (Humulin® R U-100), Placebo)
Completed
- Amnestic Mild Cognitive Impairment
- Alzheimer's Disease
- Insulin (Humulin® R U-100)
- Placebo
-
Phoenix, Arizona
- +24 more
May 14, 2020